INFN, Torino, Italy.
Phys Med Biol. 2018 Jul 17;63(14):145018. doi: 10.1088/1361-6560/aacab8.
In vivo range monitoring techniques are necessary in order to fully take advantage of the high dose gradients deliverable in hadrontherapy treatments. Positron emission tomography (PET) scanners can be used to monitor beam-induced activation in tissues and hence measure the range. The INSIDE (Innovative Solutions for In-beam DosimEtry in Hadrontherapy) in-beam PET scanner, installed at the Italian National Center of Oncological Hadrontherapy (CNAO, Pavia, Italy) synchrotron facility, has already been successfully tested in vivo during a proton therapy treatment. We discuss here the system performance evaluation with carbon ion beams, in view of future in vivo tests. The work is focused on the analysis of activity images obtained with therapeutic treatments delivered to polymethyl methacrylate (PMMA) phantoms, as well as on the test of an innovative and robust Monte Carlo simulation technique for the production of reliable prior activity maps. Images are reconstructed using different integration intervals, so as to monitor the activity evolution during and after the treatment. Three procedures to compare activity images are presented, namely Pearson correlation coefficient, Beam's eye view and overall view. Images of repeated irradiations of the same treatments are compared to assess the integration time necessary to provide reproducible images. The range agreement between simulated and experimental images is also evaluated, so as to validate the simulation capability to provide sound prior information. The results indicate that at treatment end, or at most 20 s afterwards, the range measurement is reliable within 1-2 mm, when comparing both different experimental sessions and data with simulations. In conclusion, this work shows that the INSIDE in-beam PET scanner performance is promising towards its in vivo test with carbon ions.
为了充分利用重离子治疗中可提供的高剂量梯度,有必要采用体内剂量监测技术。正电子发射断层扫描(PET)扫描仪可用于监测束引起的组织激活,从而测量射程。安装在意大利国家肿瘤重离子治疗中心(CNAO,帕维亚,意大利)同步加速器设施中的 INSIDE(束内剂量测量的创新解决方案)在体 PET 扫描仪已在质子治疗过程中成功进行了体内测试。我们在此讨论了针对未来体内测试的系统性能评估,重点分析了用碳离子束进行的治疗中获得的活性图像,以及用于产生可靠的先验活性图的创新且稳健的蒙特卡罗模拟技术的测试。使用不同的积分间隔重建图像,以便监测治疗过程中和治疗后的活性演变。提出了三种比较活性图像的方法,即 Pearson 相关系数、射束视野和整体视野。比较了相同治疗的重复照射的图像,以评估提供可重复图像所需的积分时间。还评估了模拟和实验图像之间的射程一致性,以验证模拟提供可靠先验信息的能力。结果表明,在治疗结束时,或者最多在治疗结束后 20 秒,当比较不同的实验阶段和模拟数据时,射程测量的误差在 1-2mm 以内,具有较高的可信度。总之,这项工作表明,INSIDE 体内 PET 扫描仪的性能有希望在体内用碳离子进行测试。